
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease
Commentary — Clinical Gastroenterology and Hepatology (Sept 2024)</title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease</strong><br><em>Commentary — Clinical Gastroenterology and Hepatology (Sept 2024)</em></summary>
            <div>
                <ul><li>- <b>Journal:</b> Clinical Gastroenterology and Hepatology.</li><li>- <b>Publication date:</b> September 2024.</li><li>- <b>Type:</b> AGA Institute Clinical Practice Update (expert commentary).</li><li>- <b>Link / DOI:</b> <u>https://doi.org/10.1016/j.cgh.2024.04.039</u>.</li><li>- <b>Scope:</b> Role, technique, evidence, applications, training, limitations of <b>IUS</b> in <b>IBD</b> care.</li></ul>
                
        <details>
            <summary><strong>knowledge test</strong></summary>
            <div>
                <ul><li>- What bowel wall thickness threshold on IUS combined with fecal calprotectin predicts postoperative Crohn recurrence? (give BWT and FC values).</li><li>- Within how many weeks can sonographic response (BWT reduction) be detected after biologic initiation in Crohn's disease? (give earliest interval reported).</li><li>- What absolute BWT cutoff predicted week‑8 endoscopic remission with tofacitinib in UC? (give value and its specificity).</li><li>- What reduction in BWT within 48 ± 24 hours of IV steroids predicted endoscopic response in acute severe UC? (give % and associated OR).</li><li>- How many patients are required for IBUS Module 2 hands‑on training? (give number).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Executive summary</strong><br><em>Key takeaways for clinicians</em></summary>
            <div>
                <ul><li>- <b>IUS</b> = bedside, noninvasive, radiation‑free tool to assess bowel wall and complications in <b>IBD</b>.</li><li>- Comparable accuracy to <b>MRE</b> and <b>CTE</b> for ileal disease and complications when performed by trained operators.</li><li>- Best used for point‑of‑care monitoring, early treatment response, and special populations (pregnancy, comorbidities).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IUS technique and equipment</strong><br><em>Practical exam workflow</em></summary>
            <div>
                <ul><li>- Equipment: high‑resolution US system, <b>low‑frequency convex</b> transducer + <b>high‑frequency linear</b> transducer for color Doppler.</li><li>- Typical exam: global survey with convex probe ---> targeted linear probe for <b>BWT</b> and Doppler; no prep, fasting, or contrast required.</li><li>- Key findings: <b>BWT</b>, <b>bowel wall hyperemia</b> (color Doppler), mesenteric fat, loss of stratification, lymphadenopathy, strictures/fistula/abscess.</li></ul>
                
        <details>
            <summary><strong>Practical tip: probes and patient habitus</strong><br><em>When to use which probe</em></summary>
            <div>
                <ul><li>- Use <b>convex</b> for global survey; <b>linear</b> for detailed wall assessment and Doppler.</li><li>- In slim patients and children, a <b>linear probe alone</b> often suffices.</li><li>- Expect limited view in large body habitus or overlying bowel gas; consider alternative imaging if inadequate.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IUS measurements, thresholds & actionable criteria</strong><br><em>Numbers clinicians must memorize</em></summary>
            <div>
                <ul><li>- Primary metric = <b>BWT</b>; secondary = <b>Doppler hyperemia</b> and loss of stratification.</li><li>- Use numeric thresholds to guide action and prognosis rather than clinical symptoms alone.</li><li>- See separate disease nodes for validated cutoffs and response criteria.</li></ul>
                
        <details>
            <summary><strong>Postoperative Crohn's recurrence criteria</strong></summary>
            <div>
                <ul><li>- Postop recurrence detection: neo‑terminal ileum/adjacent colon BWT of <q><b>≥3 mm</b></q> + FC of <q><b>≥50 µg/g</b></q> signals recurrence.</li><li>- This combined approach had a PPV of <q><b>74%</b></q> (95% CI, 63%–84%) and NPV of <q><b>71%</b></q> (95% CI, 42%–92%) (See Table 1 and cited study).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Definitions of sonographic treatment response and healing (CD)</strong></summary>
            <div>
                <ul><li>- <b>Sonographic response:</b> <q><b>≥25% reduction</b></q> in BWT from baseline.</li><li>- <b>Transmural healing:</b> normalization of all IUS parameters (BWT, Doppler, stratification).</li><li>- Early lack of sonographic response predicts poor later endoscopic outcome (NPV <q><b>73%</b></q> for week 48).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Ulcerative colitis IUS cutoffs</strong></summary>
            <div>
                <ul><li>- Absolute BWT <q><b><2.8 mm</b></q> predicted week‑8 endoscopic remission with <b>tofacitinib</b> (sensitivity <q><b>73%</b></q>, specificity <q><b>100%</b></q>, AUC 0.87).</li><li>- A <q><b>32% reduction</b></q> in BWT predicted week‑8 endoscopic response (sens <q><b>71%</b></q>, spec <q><b>90%</b></q>, AUC 0.87).</li><li>- In acute severe UC, a <q><b>≥20% reduction</b></q> in BWT within ~48h of IV steroids associated with higher endoscopic response (OR <q><b>22.6</b></q>) and lower need for rescue biologic (OR <q><b>6.3</b></q>).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Comparison to alternative modalities</strong><br><em>Table 1 summary</em></summary>
            <div>
                <ul><li>- <b>IUS</b>: no prep, no radiation, point‑of‑care, low cost ($). Limits: poor stomach/esophagus/rectum view, no interventions, gas/obesity may limit image.</li><li>- <b>MRE</b>: requires oral/IV contrast and fasting; high cost ($$$); stronger for extent of deep small bowel disease; limited for colon vs IUS.</li><li>- <b>CTE</b> and <b>VCE</b>: specific advantages (CT for availability, VCE for mucosal small lesions) but radiation (CT) and capsule retention (VCE) limit use.</li></ul>
                
        <details>
            <summary><strong>Accuracy & reliability data</strong></summary>
            <div>
                <ul><li>- METRIC & other studies: IUS ≈ MRE/CTE for ileal CD activity and for complications (fistula/abscess/stricture) (See METRIC trial/Table 1).</li><li>- Inter‑observer agreement (small bowel activity): IUS <q><b>82%</b></q> (κ 0.64/0.61) vs MRE <q><b>69%</b></q> (κ 0.36/0.56) in a 38‑patient substudy.</li><li>- Meta‑analyses: comparable diagnostic accuracy for complications across IUS, MRE, CTE.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Clinical applications: screening, monitoring, decision making</strong></summary>
            <div>
                <ul><li>- Use IUS as a noninvasive screening tool to rule out intestinal inflammation and to triage need for ileocolonoscopy.</li><li>- Use IUS to monitor treatment response and enable timely treatment adjustment at point of care.</li><li>- IUS can detect complications (stricture, fistula, abscess, phlegmon) and guide urgency of cross‑sectional imaging or surgery.</li></ul>
                
        <details>
            <summary><strong>Screening and triage example</strong></summary>
            <div>
                <ul><li>- Positive IUS (increased BWT/hyperemia) expedites diagnostic ileocolonoscopy.</li><li>- Postop CD recurrence: BWT <q><b>≥3 mm</b></q> + FC <q><b>≥50 µg/g</b></q> → PPV <q><b>74%</b></q>, NPV <q><b>71%</b></q> (use to prioritize endoscopy).</li><li>- IUS can substitute or complement fecal biomarkers when stool access is limited.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Crohn's disease — monitoring and prognostic use</strong></summary>
            <div>
                <ul><li>- IUS identifies treatment response early; changes visible within weeks to months after biologic start.</li><li>- Higher baseline BWT predicts reduced chance of transmural healing after 1 year.</li><li>- IUS findings can guide treat‑to‑target strategies and predict failure early.</li></ul>
                
        <details>
            <summary><strong>Timelines & effect sizes in Crohn's</strong></summary>
            <div>
                <ul><li>- Sonographic response (BWT ↓ ≥25%) and transmural healing rates at 48 weeks with ustekinumab: <q><b>46.3%</b></q> and <q><b>24.1%</b></q>, respectively (STARDUST IUS study).</li><li>- Lack of sonographic response at week 4 → NPV for poor week‑48 endoscopic response: <q><b>73%</b></q>.</li><li>- Patients with higher baseline BWT were <q><b>42% less likely</b></q> to achieve transmural healing at 1 year, independent of therapy.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Early BWT reduction predicts endoscopic response</strong></summary>
            <div>
                <ul><li>- A <q><b>≥18% reduction</b></q> in BWT at 4–8 weeks after anti‑TNF start predicted ~<q><b>10×</b></q> higher odds of endoscopic response at weeks 12–32.</li><li>- Use early sonographic change to consider escalation or switch therapy rather than waiting months for endoscopy.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Ulcerative colitis — monitoring & acute severe disease</strong></summary>
            <div>
                <ul><li>- IUS accurately tracks treatment response in UC and can show normalization quickly after therapy change.</li><li>- Useful in hospitalized acute severe UC to predict steroid response early and avoid escalation.</li><li>- Evidence stronger for active UC than for monitoring remission — data gap remains for IUS in quiescent UC.</li></ul>
                
        <details>
            <summary><strong>Key UC response metrics</strong></summary>
            <div>
                <ul><li>- BWT normalization can occur as soon as <q><b>2 weeks</b></q> after treatment change (prospective data, TRUST&UC).</li><li>- Tofacitinib cohort: absolute BWT <q><b><2.8 mm</b></q> predicted week‑8 remission (sens <q><b>73%</b></q>, spec <q><b>100%</b></q>, AUC 0.87).</li><li>- Acute severe UC: BWT ↓ ≥20% within ~48h after IV steroids → endoscopic response OR <q><b>22.6</b></q>; less need for rescue biologic OR <q><b>6.3</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Special populations & patient experience</strong><br><em>Pregnancy, comorbidity, equity</em></summary>
            <div>
                <ul><li>- <b>Pregnancy:</b> IUS avoids radiation/sedation; sensitivity <q><b>84%</b></q>, specificity <q><b>98%</b></q> vs clinical/FC; colon & terminal ileum visualized in up to <q><b>92%</b></q> in 3rd trimester.</li><li>- <b>Serious comorbidities:</b> beneficial when contrast or sedation contraindicated (eg, renal failure, high anesthesia risk).</li><li>- <b>Equity:</b> point‑of‑care IUS can improve access for rural/underserved patients by reducing travel and appointment burden.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IUS training, implementation & billing</strong></summary>
            <div>
                <ul><li>- Program setup: choose machine (full system vs portable), transducers, image storage (DICOM/local server/cloud) and HIPAA compliance.</li><li>- Workflow models: same‑day dual appointment, in‑clinic scan before consult, or standalone IUS clinic with referrals.</li><li>- Billing: no dedicated CPT yet; use existing codes (eg, <b>76705</b> = limited abdominal US) and follow institutional guidance.</li></ul>
                
        <details>
            <summary><strong>IBUS certification pathway & training volume</strong></summary>
            <div>
                <ul><li>- IBUS training: Module 1 = introductory course; Module 2 = hands‑on with at least <q><b>40 patients</b></q> at a certified center; Module 3 = advanced workshop + final exam.</li><li>- No official US gastroenterology IUS certification yet; expect national credentialing efforts and maintenance requirements.</li><li>- Radiology support can be used, but point‑of‑care GI provider skill increases timeliness of decision making.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Implementation pitfalls and mitigation</strong></summary>
            <div>
                <ul><li>- Pitfall: operator dependence → mitigate with structured training, protocols, and interobserver calibration.</li><li>- Pitfall: lack of image storage/integration → mitigate by selecting DICOM/EHR solutions early.</li><li>- Pitfall: workflows/billing unclear → pilot local models and align documentation templates (see cited billing guide e2).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Limitations and when not to rely on IUS</strong></summary>
            <div>
                <ul><li>- Poor visualization: proximal/mid small bowel and rectum can be inadequately assessed; <b>MRE/CTE</b> or endoscopy may be needed for extent and deep pelvic disease.</li><li>- Technical limits: limited field‑of‑view makes measuring disease length difficult for > <q><b>10 cm</b></q> small bowel segments.</li><li>- Not suitable for dysplasia surveillance or tasks requiring tissue sampling or dilation; endoscopy remains gold standard for mucosal assessment in these cases.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Practical pitfalls & common misunderstandings</strong></summary>
            <div>
                <ul><li>- Misunderstanding: IUS replaces all imaging — it complements MRE/CTE/endoscopy; choose modality by question (extent vs mucosa vs complications).</li><li>- Pitfall: over‑reliance on single parameter; interpret <b>BWT</b> with Doppler, stratification, and clinical context.</li><li>- Expectation: training time required — initial learning curve but good interobserver reliability after training.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Evidence gaps & research directions</strong></summary>
            <div>
                <ul><li>- Need for multicenter, prospective studies on IUS‑guided treat‑to‑target outcomes and cost effectiveness.</li><li>- Need validation for IUS in UC remission monitoring and dysplasia detection (currently insufficient).</li><li>- Standardization: widespread adoption of scoring systems (eg, IBUS‑SAS) and integration into trials to include transmural healing endpoints.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Conclusions & clinical action points</strong></summary>
            <div>
                <ul><li>- Integrate IUS for point‑of‑care monitoring to detect early treatment response and complications and to triage endoscopy.</li><li>- Memorize key thresholds: postoperative BWT <q><b>≥3 mm</b></q>, FC <q><b>≥50 µg/g</b></q>; UC BWT <q><b><2.8 mm</b></q> predicts remission; early % BWT reductions predict outcomes.</li><li>- Prioritize training, storage solutions, and local workflows to realize benefits and ensure reliability.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Table & figure references</strong><br><em>Where to find detailed illustrations</em></summary>
            <div>
                <ul><li>- See <b>Figure 1</b> for bowel wall layer anatomy and key sonographic features of activity.</li><li>- See <b>Table 1</b> for side‑by‑side comparison of IUS, MRE, CTE, VCE, and endoscopy (prep, risks, cost, limitations).</li><li>- Supplementary materials available at journal site for expanded methods and billing templates (see DOI link).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
    </div>
    
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
